Kingdon Capital Management’s Guardant Health GH Stock Holding History

Kingdon Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-485,000	Closed	-$11.1M	–	86
2024 Q3	$11.1M	Sell	485,000 -185,200	-28%	-$5.24M	1.23%	38
2024 Q2	$19.4M	Buy	+670,200	New	+$15.6M	2.07%	11
2023 Q3	–	Sell	-296,951	Closed	-$10.6M	–	88
2023 Q2	$10.6M	Buy	+296,951	New	+$8.53M	1%	34
2022 Q4	–	Sell	-123,100	Closed	-$6.63M	–	64
2022 Q3	$6.63M	Buy	+123,100	New	+$6.32M	0.85%	27
2022 Q2	–	Sell	-145,800	Closed	-$7.22M	–	82
2022 Q1	$9.66M	Buy	+145,800	New	+$9.98M	1.01%	25

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Kingdon Capital Management's GH Position: Q4 2024 in Review

Kingdon Capital Management sold out of Guardant Health (GH) in Q4 2024, closing a stake of 485,000 shares — an estimated $11.1M sold.

Kingdon Capital Management first reported a position in GH in Q1 2022 and held it in 5 quarters. The position peaked at $19.4M in Q2 2024. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

Kingdon Capital Management reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
Kingdon Capital Management sold 485,000 Guardant Health shares in Q4 2024, an estimated $11.1M.
Kingdon Capital Management first reported a position in Guardant Health in Q1 2022 and held it in 5 quarters.
Kingdon Capital Management's Guardant Health position peaked at $19.4M in Q2 2024.
298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Kingdon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.